• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin.

作者信息

Grubb N R, Bloomfield P, Ludlam C A

出版信息

BMJ. 1998 Dec 5;317(7172):1540-2. doi: 10.1136/bmj.317.7172.1540.

DOI:10.1136/bmj.317.7172.1540
PMID:9836650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1114382/
Abstract
摘要

相似文献

1
The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin.肝素泵的终结？低分子量肝素相较于普通肝素具有诸多优势。
BMJ. 1998 Dec 5;317(7172):1540-2. doi: 10.1136/bmj.317.7172.1540.
2
A meta-analysis of controlled clinical trials comparing low-molecular weight heparins with unfractionated heparin in unstable angina.一项比较低分子量肝素与普通肝素治疗不稳定型心绞痛的对照临床试验的荟萃分析。
Indian Heart J. 2001 Mar-Apr;53(2):197-202.
3
Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.低分子量肝素与普通肝素治疗不稳定型冠心病的比较
N Engl J Med. 1998 Jan 8;338(2):129-30; author reply 131. doi: 10.1056/NEJM199801083380213.
4
Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.近期关于低分子量肝素治疗静脉血栓栓塞症和不稳定型心绞痛的临床试验。
Curr Opin Hematol. 1998 Sep;5(5):360-5.
5
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.固定剂量皮下注射低分子量肝素与调整剂量普通肝素治疗静脉血栓栓塞症的比较
Cochrane Database Syst Rev. 2000(2):CD001100. doi: 10.1002/14651858.CD001100.
6
Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.每日一次使用帕肝素与普通肝素治疗不稳定型心绞痛的疗效比较：PRIME CARE研究
Indian Heart J. 2005 Nov-Dec;57(6):648-54.
7
[Thrombosis and thrombocytopenia associated with the use of unfractionated heparin in a female patient with unstable angina].[一名不稳定型心绞痛女性患者使用普通肝素后出现的血栓形成和血小板减少症]
Rev Clin Esp. 1991 Oct;189(5):224-6.
8
The end of the heparin pump? Dosage regimens for low molecular weight heparins differ.肝素泵的终结？低分子量肝素的给药方案有所不同。
BMJ. 1999 Aug 28;319(7209):575-6. doi: 10.1136/bmj.319.7209.575a.
9
[Low molecular weight heparin--1998 status].[低分子量肝素——1998年现状]
Praxis (Bern 1994). 1999 Apr 29;88(18):802-7.
10
[Unstable angina pectoris: preventing the infarct. Thrombosis ABC, 14].
MMW Fortschr Med. 2000 Mar 30;142(13):36.

引用本文的文献

1
The end of the heparin pump? Dosage regimens for low molecular weight heparins differ.肝素泵的终结？低分子量肝素的给药方案有所不同。
BMJ. 1999 Aug 28;319(7209):575-6. doi: 10.1136/bmj.319.7209.575a.

本文引用的文献

1
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.抗凝药物治疗肺栓塞的对照试验。
Lancet. 1960 Jun 18;1(7138):1309-12. doi: 10.1016/s0140-6736(60)92299-6.
2
Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.
Am J Cardiol. 1997 Sep 4;80(5A):30E-34E. doi: 10.1016/s0002-9149(97)00487-6.
3
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.低分子量肝素与普通肝素治疗急性肺栓塞的比较。THESEE研究组。替扎肝素或标准肝素：肺栓塞评估。
N Engl J Med. 1997 Sep 4;337(10):663-9. doi: 10.1056/NEJM199709043371002.
4
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.低分子量肝素与普通肝素治疗不稳定型冠状动脉疾病的比较。皮下注射依诺肝素治疗非Q波冠状动脉事件研究组的疗效与安全性。
N Engl J Med. 1997 Aug 14;337(7):447-52. doi: 10.1056/NEJM199708143370702.
5
Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.低分子量肝素、普通肝素和华法林在骨科手术中预防血栓栓塞的疗效与安全性：一项随机临床试验的荟萃分析
Haemostasis. 1997 Mar-Apr;27(2):75-84. doi: 10.1159/000217437.
6
Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
Circulation. 1996 Sep 1;94(5):911-21. doi: 10.1161/01.cir.94.5.911.
7
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.在阿司匹林中添加肝素可降低不稳定型心绞痛患者心肌梗死和死亡的发生率。一项荟萃分析。
JAMA. 1996 Sep 11;276(10):811-5.
8
A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.低剂量肝素与低分子量肝素预防严重创伤后静脉血栓栓塞的比较。
N Engl J Med. 1996 Sep 5;335(10):701-7. doi: 10.1056/NEJM199609053351003.
9
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.与在家皮下注射低分子量肝素相比，在医院静脉注射普通肝素治疗静脉血栓形成。塔斯曼研究小组。
N Engl J Med. 1996 Mar 14;334(11):682-7. doi: 10.1056/NEJM199603143341102.
10
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.主要在家中使用的低分子量肝素与在医院使用的普通肝素治疗近端深静脉血栓形成的比较。
N Engl J Med. 1996 Mar 14;334(11):677-81. doi: 10.1056/NEJM199603143341101.